How do we minimise operational risks and prevent delays?

How do we minimise operational risks and prevent delays?

A well-designed protocol alone does not guarantee success — operational management must also be strong.
At Biostat®, our model focuses not only on documentation quality, but above all on risk management and maintaining the study timeline.

From experience, we know that delays usually stem from small organisational issues, poor communication or resource miscalculations.
To avoid these, we implement proven practices from the planning stage onward.

Our proven risk-management practices

1. Building a realistic study timeline

We analyse every stage — documentation, ethics/regulatory approvals, recruitment, monitoring and reporting — and create a timeline with built-in safety margins to prevent cascading delays.

2. Thorough feasibility analysis

Before study initiation, we assess site potential, recruitment capabilities, competing projects and demographic/epidemiological factors.
This allows us to predict recruitment pace accurately and select sites that can realistically meet study expectations.

3. Optimising the protocol

Small adjustments — simplifying inclusion criteria, merging procedures, reducing visits — can significantly accelerate recruitment and reduce costs.
Our methodologists and biostatisticians advise on balancing scientific value with operational feasibility.

4. Dedicated Project Manager

Every Biostat® project has a dedicated PM who coordinates all operational aspects and serves as a single point of contact for the sponsor and sites.

5. Transparent progress reporting

Sponsors receive regular reports, dashboards and KPI updates (recruitment rate, visit status, site performance, financials).
This transparency facilitates quick decision-making.

6. Real-time risk monitoring

Using RBM (Risk-Based Monitoring) and the Risk Management Plan, we quickly detect deviations before they affect the timeline.
Quality metrics such as query rate or completeness rate help identify issues early.

7. Ongoing communication with sites

We maintain close contact via calls, online meetings, newsletters and system reminders.
Efficient communication solves issues early and keeps sites engaged and coordinated.

8. Built-in flexibility and buffers

We plan timeline buffers for regulatory decisions, contracts and logistics.
This ensures resilience against unexpected delays.

The outcome? Stability and peace of mind

With strong project management and continuous risk oversight, Biostat® maintains timeline stability and detects deviations early.
Sponsors gain:

• predictable study duration,
• fewer unplanned delays,
• reduced corrective costs,
• and smooth project delivery.

Well-planned studies succeed not just because of documentation — but because of people and risk management. This is where Biostat® stands out.

 

Other questions: Design and implementation of the study

See also

When and how should protocol amendments be implemented, and what are the consequences? When and how should protocol amendments be implemented, and what are the consequences?
Amendments to a clinical or observational study protocol are permissible, but they are always a sensitive aspect of project execution. The protocol is the ov...
How to monitor patient recruitment and verify recruitment plans? How to monitor patient recruitment and verify recruitment plans?
Monitoring patient recruitment is one of the key elements of managing a clinical or observational study, as both the pace and quality of recruitment directly...
What are the roles and responsibilities of the Sponsor, CRO, and research site during study conduct? What are the roles and responsibilities of the Sponsor, CRO, and research site during study conduct?
The roles and responsibilities of the Sponsor, the CRO, and the research site during the conduct of a clinical or observational study are clearly defined by ...
Copyright© 2023 Biostat